BRCA1 and cancer: ,24,25,26 Furthermore, the generation of resistance through the reactivation of HR through mutations or epigenetic regulation of BRCA1, and other "BRCAness'' genes is a significant challenge in PARPi therapy that has been observed in diverse cancers.6